NCT00452621已完成4 期
A Phase IV, Uncontrolled, Open-Label, Multi-Center Study in Children and Adolescents: Evaluation of Long-Term Immunogenicity in Subjects Boosted With a New Pediatric TBE Vaccine (Free of Protein-Derived Stabilizer) in Study V48P4E1, Five Years After First Booster Immunization
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- Novartis
- 入组人数
- 235
- 试验地点
- 16
- 主要终点
- 1) To investigate the kinetics of the immune response of subjects who participated in studies V48P4 (primary immunization), V48P4E1 (first booster immunization) and V48P4E2 (serological follow-up) with respect to antibody titers in terms of:· percentage
研究概览
简要总结
blood draw five years after booster-immunization with TBE vaccine to investigate immunogenicity in children
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Single Group
- 主要目的
- Prevention
- 盲法
- None
入排标准
- 年龄范围
- 6 Years 至 16 Years（Child）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Healthy volunteers of both sexes aged >1 years at the time of enrollment in V48P4 who participated in studies V48P4E1 and V48P4E2, and who/whose parents or legal guardians are willing to sign informed consent.
排除标准
- 未提供
结局指标
主要结局
1) To investigate the kinetics of the immune response of subjects who participated in studies V48P4 (primary immunization), V48P4E1 (first booster immunization) and V48P4E2 (serological follow-up) with respect to antibody titers in terms of:· percentage
次要结局
- (2) To investigate the kinetics of the immune response of subjects who participated in studies V48P4 (primary immunization), V48P4E1 (first booster immunization) and V48P4E2 (serological follow-up) in terms of:· percentage of subjects with antibody conce
研究者
研究点 (16)
Loading locations...
相似试验
已完成
4 期
Safety and Long-term Evaluation (up to 5 Years) of First Booster Immunization With Novartis' TBE Vaccine for Adults in Adolescents and AdultsTick Born EncephalitisNCT00387634Novartis Vaccines323
已完成
不适用
Study to Investigate the Seropersistence of TBE Virus Antibodies Approx. 3 Years After a Booster Vaccination With FSME-IMMUN 0.25 mL JUNIOR in ChildrenEncephalitis, Tick-borneNCT00163618Pfizer
已完成
4 期
TBE Seropersistence up to 10 Years After First Booster in AdultsTick-borne Encephalitis (TBE)NCT01582698Pfizer243
已完成
4 期
TBE Antibody Persistence and Booster Vaccination Study in Adults (Follow-up to Study 223)Encephalitis, Tick-BorneNCT00503529Pfizer314
已完成
4 期
Evaluation of Long-Term Immunogenicity in Subjects Boosted With a TBE Vaccine for AdultsEncephalitis, Tick-BorneNCT00311493Novartis179